Tabriz University of Medical Sciences
Iran
Clinical Trials
1.4k
Active:2
Completed:533
Trial Phases
6 Phases
Early Phase 1:11
Phase 1:47
Phase 2:236
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1407 trials with phase data)• Click on a phase to view related trials
Not Applicable
695 (49.4%)Phase 3
405 (28.8%)Phase 2
236 (16.8%)Phase 1
47 (3.3%)Phase 4
13 (0.9%)Early Phase 1
11 (0.8%)The Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Mild to Moderate Alzheimer's Disease
Phase 2
Not yet recruiting
- Conditions
- Alzheimer Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-21
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Tabriz University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT06840054
Efficacy of OsteoBor in Postmenopausal Osteoporosis
Phase 2
Not yet recruiting
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-02-05
- Lead Sponsor
- Tabriz University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT06809816
Effect of PMSCs and Their Secretome for the Treatment of GvHD
Phase 3
Completed
- Conditions
- GVHD
- First Posted Date
- 2024-06-21
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Tabriz University of Medical Sciences
- Target Recruit Count
- 60
- Registration Number
- NCT06469411
- Locations
- 🇮🇷
Abolfazl Barzegari, Tabriz, East Azerbaijan, Iran, Islamic Republic of
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma
Phase 1
Not yet recruiting
- Conditions
- Renal Cell Carcinoma
- Interventions
- Drug: Sodium Pentaborate
- First Posted Date
- 2023-04-04
- Last Posted Date
- 2023-04-04
- Lead Sponsor
- Tabriz University of Medical Sciences
- Target Recruit Count
- 30
- Registration Number
- NCT05798455
- Locations
- 🇮🇷
Imam Reza hospital and Clinic of Salamat, Tabriz, East Azarbayejan, Iran, Islamic Republic of
Safety and Efficacy of Sodium Pentaborate Pentahydrate in People With Overweight and Obesity
Phase 1
Not yet recruiting
- Conditions
- Overweight and Obesity
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Tabriz University of Medical Sciences
- Target Recruit Count
- 120
- Registration Number
- NCT05741606
- Locations
- 🇮🇷
Imam Reza hospital and Clinic of Salamat, Tabriz, East Azarbayejan, Iran, Islamic Republic of
- Prev
- 1
- 2
- 3
- Next
News
No news found